Consolidation in the hospital and healthcare delivery sectors has better positioned larger hospital systems to negotiate lower prices for medical device products and technologies. This trend has introduced new levels of pricing pressure on manufacturers and is driving interest in alternative pricing models — including value-based agreements — across the sector.
Roundtable: Transitioning Medical Affairs to strategically co-lead clinical development and commercialization efforts
In May 2023, CRA’s Life Sciences Practice held a roundtable discussion with Medical Affairs leaders in Lisbon on best practices in transitioning from a...